In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically 'undruggable' protein, in just two months. This ...
In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ?-catenin, a historically "undruggable" protein, in just two months. This ...
In neuroscientific research, gaining a deep understanding of the human nervous system's structure and dynamics is pivotal. Despite remarkable advancements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback